bpc-157 human clinical trial evidence review trials safety regulatory status BPC-157 bpc-157 human clinical trials evidence
Description
smaller alpha-smooth muscle actin (-SMA) distribution
Pain may be noted with intramuscular injection
Noda H, Fujikado T
The blend is supplied as a co-lyophilized powder containing 10mg BPC-157 and 10mg TB-500 per vial, packaged according to professional research standards
